The number of people with susceptibility test result for rifampicin in Angola
Angola: The number of people with susceptibility test result for rifampicin was 33.12 in 2021. ◆ Volatile
Latest (2021)
33.12
Change on year
up 838.2%
World rank
130th
of 146 countries
All-time high
85.07
in 2019
All-time low
0.1672
in 2018
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Angola, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
Angola recorded 33.12 for the number of people with susceptibility test result for rifampicin in 2021.
The figure is up 838.2% on the previous year and up 4,508.4% over five years.
Angola ranks 130th of 146 countries on this measure, in the bottom quarter.
The number of people with susceptibility test result for rifampicin in Angola, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 0.7187 | — |
| 2018 | 0.1672 | -76.7% |
| 2019 | 85.07 | +50777.2% |
| 2020 | 3.53 | -95.9% |
| 2021 | 33.12 | +838.2% |
Angola compared with similar countries
- Angola's 33.12 is below the median for lower middle income countries, which is 78.77, 42% of the median. (32 countries reporting)
- Angola's 33.12 is below the median for Sub-Saharan Africa, which is 61.16, 54% of the median. (32 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 28.65 | 0.1672 | 85.07 | 3 |
| 2020s | 18.32 | 3.53 | 33.12 | 2 |
Countries ranked near Angola
More health data for Angola
- Un projection of annual infant deaths, annual growth rate -1.27 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 1.05 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 740.2 deaths per 1,000 people (2090)
- Number of infants who die before age 1 31,754 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 79 (2025)
- Population ages 00-04, female, annual growth rate 1.97 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0823 units per person (2025)
- Population ages 00-04, male, annual growth rate 2.01 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Angola?
- The number of people with susceptibility test result for rifampicin in Angola was 33.12 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Angola?
- The highest recorded value was 85.07 in 2019.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Angola?
- The lowest recorded value was 0.1672 in 2018.
- How does Angola rank for the number of people with susceptibility test result for rifampicin?
- Angola ranks 130th out of 146 countries with data for 2021.
- Where does this Angola data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).